Showing results (721-730 of 732) with videos related to

Sort By:
Pageof 74
BMC Complementary Medicine and Therapies|April 24, 2025
Brief verbal intervention to address inappropriate prescriptions of chinese patent medicines among western practitioners in primary health care (BRAVERY): a study protocol for an unannounced standardized patient experiment with a factorial design randomized controlled trial in ChinaQing Zhao, Lin Lin, Ada Kwan, et al.
Nature Communications|June 28, 2022
Lentivector cryptic splicing mediates increase in CD34+ clones expressing truncated HMGA2 in human X-linked severe combined immunodeficiencySuk See De Ravin, Siyuan Liu, Colin L Sweeney, et al.
Nature Communications|November 18, 2020
Author Correction: Transcriptomic and cellular decoding of regional brain vulnerability to neurogenetic disordersJakob Seidlitz, Ajay Nadig, Siyuan Liu, et al.
Blood|February 24, 2021
Enhanced homology-directed repair for highly efficient gene editing in hematopoietic stem/progenitor cellsSuk See De Ravin, Julie Brault, Ronald J Meis, et al.
Nature Communications|July 5, 2020
Transcriptomic and cellular decoding of regional brain vulnerability to neurogenetic disordersJakob Seidlitz, Ajay Nadig, Siyuan Liu, et al.
Npj Computational Materials|August 25, 2025
DPA-2: a large atomic model as a multi-task learnerDuo Zhang, Xinzijian Liu, Xiangyu Zhang, et al.
Journal of Medicinal Chemistry|March 18, 2025
From DNA-Encoded Library Screening to AM-9747: An MTA-Cooperative PRMT5 Inhibitor with Potent Oral In Vivo EfficacyIan Sarvary, Mikkel Vestergaard, Loris Moretti, et al.
Translational Psychiatry|September 19, 2019
NRXN1 is associated with enlargement of the temporal horns of the lateral ventricles in psychosisNey Alliey-Rodriguez, Tamar A Grey, Rebecca Shafee, et al.
Cancer Discovery|September 16, 2024
AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted CancersBrian Belmontes, Katherine K Slemmons, Chun Su, et al.
Journal of Medicinal Chemistry|March 27, 2025
Discovery of AMG 193, an MTA-Cooperative PRMT5 Inhibitor for the Treatment of MTAP-Deleted CancersLiping H Pettus, Matthew Bourbeau, Nuria A Tamayo, et al.
Pageof 74